Carles Aracil

机构：Hospital Universitari Arnau de Vilanova, Centre for Biomedical Network Research on Rare Diseases, Instituto de Investigación Biomédica de Lleida, Medical Research Network · ORCID：0000-0002-8228-9041

发表论文 55 篇 · 总被引 5202 次 · h-index 23

代表论文

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial (2019 · The Lancet · 被引 694)
A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis (2017 · Hepatology · 被引 80)
Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis (2021 · Journal of Hepatology · 被引 71)
Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first‐line therapies (2017 · Hepatology · 被引 71)
Short-term hemodynamic effects of β-blockers influence survival of patients with decompensated cirrhosis (2020 · Journal of Hepatology · 被引 56)
Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis (2024 · Journal of Hepatology · 被引 29)